Cipher Pharmaceuticals Price on November 23, 2024

CPHRFDelisted Stock  USD 2.57  0.00  0.00%   
If you're considering investing in Cipher OTC Stock, it is important to understand the factors that can impact its price. As of today, the current price of Cipher Pharmaceuticals stands at 2.57, as last reported on the 27th of November, with the highest price reaching 2.57 and the lowest price hitting 2.57 during the day. We have found twenty-five technical indicators for Cipher Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please confirm Cipher Pharmaceuticals' Mean Deviation of 3.86, downside deviation of 10.24, and Risk Adjusted Performance of 0.0494 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Cipher OTC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
CPHRF
Based on monthly moving average Cipher Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cipher Pharmaceuticals by adding Cipher Pharmaceuticals to a well-diversified portfolio.

Cipher Pharmaceuticals Valuation on November 23, 2024

It is possible to determine the worth of Cipher Pharmaceuticals on a given historical date. On November 23, 2024 Cipher was worth 2.57 at the beginning of the trading date compared to the closed value of 2.57. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cipher Pharmaceuticals otc stock. Still, in general, we apply an absolute valuation method to find Cipher Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cipher Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cipher Pharmaceuticals' related companies.
 Open High Low Close Volume
11/27/2024
  2.57    2.57    2.57    2.57    0.00  
Backtest Cipher Pharmaceuticals  |  Cipher Pharmaceuticals History  |  Cipher Pharmaceuticals Valuation 
Open Value
2.57
2.57
Closing Value
2.57
Upside

Cipher Pharmaceuticals Trading Date Momentum on November 23, 2024

Cipher Pharmaceuticals Fundamentals Correlations and Trends

By evaluating Cipher Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cipher Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cipher financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Cipher Pharmaceuticals OTC Stock history

Cipher Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cipher is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cipher Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cipher Pharmaceuticals stock prices may prove useful in developing a viable investing in Cipher Pharmaceuticals
Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. Cipher Pharmaceuticals Inc. was founded in 2000 and is headquartered in Oakville, Canada. Companhia Siderurgica is traded on OTC Exchange in the United States.

Cipher Pharmaceuticals OTC Stock Technical Analysis

Cipher Pharmaceuticals technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
A focus of Cipher Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Cipher Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Cipher Pharmaceuticals Period Price Range

Low
November 27, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Cipher Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on OTCQX Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Cipher Pharmaceuticals November 27, 2024 Market Strength

Market strength indicators help investors to evaluate how Cipher Pharmaceuticals otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cipher Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Cipher Pharmaceuticals otc stock market strength indicators, traders can identify Cipher Pharmaceuticals entry and exit signals to maximize returns

Cipher Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Cipher Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Cipher OTC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cipher to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Consideration for investing in Cipher OTC Stock

If you are still planning to invest in Cipher Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cipher Pharmaceuticals' history and understand the potential risks before investing.
Global Correlations
Find global opportunities by holding instruments from different markets
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets